🌅 Pre-Market Pulse

S&P Futures 7,360.50 ▲ +52.75 (+0.72%)	Nasdaq Futures 28,595.25 ▲ +281.50 (+0.99%)	Dow Futures 49,999.00 ▲ +472.00 (+0.95%)
10Y Treasury 4.42% ▼ -0.03%	US Dollar 97.64 ▼ -0.66 (-0.67%)	Bitcoin $82,413 ▲ +$1,506 (+1.86%)

Good morning! Wednesday is shaping up to be a genuinely interesting session. Futures are flashing green across all three major indexes, Treasury yields are nudging lower, and the dollar is softening just enough to give risk assets room to breathe. Disney drops its first earnings report under new CEO Josh D'Amaro this morning, and that alone makes today worth watching closely. Pull up a chair, because here's your morning rundown.

👀 What to Watch Today

The single biggest event on the calendar this morning is Disney's fiscal second-quarter earnings report, hitting before the opening bell. This is D'Amaro's debut quarter as CEO, so analysts and investors will be parsing every line of guidance for clues about where he plans to take the House of Mouse. Streaming profitability, theme park demand, and any commentary on advertising revenue will all be under the microscope.

Beyond DIS, keep an eye on how markets digest the overnight developments out of Europe, particularly the Bayer and Philips results that came through earlier. Sector rotation between healthcare and industrials could be a quiet but meaningful undercurrent throughout the session. The FOMC is not meeting today, but Fed commentary remains a live wire given the 10-year yield sitting at 4.42%.

On the macro side, a softer dollar at 97.64 is a tailwind for multinational earnings and could give a modest lift to commodity-linked names. Bitcoin climbing to 82,413 overnight suggests some renewed risk appetite creeping back into speculative corners of the market, which often telegraphs broader sentiment heading into the open.

Here's the BIG PROBLEM with the SpaceX IPO [ad]

🌏 Overnight Recap

European markets got a boost overnight from a pair of solid earnings beats. Philips reported first-quarter revenues and margins above expectations, driven by strong order flow in North America, sending PHG higher in overseas trading. Novo Nordisk also delivered better-than-expected adjusted operating profit in Q1, which is meaningful for NVO holders given the intense competition heating up in the weight-loss drug space.

Bayer made headlines with new clinical data showing its experimental blood thinner asundexian meaningfully reduces the frequency and severity of ischemic strokes. That is a significant development for BAYRY, which has been navigating a rough stretch. A clinical win of this magnitude does not come along every quarter, and the market noticed.

On the airline front, Lufthansa flagged an expected 2 billion dollar hit to fuel costs tied to the ongoing Middle East conflict, weighing on DLAKY and casting a shadow over the broader airline sector. Santander is also in the news after the Financial Times reported the bank plans to retire the TSB brand following its acquisition of Banco Sabadell's UK unit, a branding move that signals deeper integration ahead for SAN.

The secret currency of Elon Musk? [ad]

📊 Pre-Market Movers

Tesla is in the pre-market spotlight this morning, but not for the best reason. TSLA faces a recall of 218,868 vehicles in the U.S. due to delayed rearview camera images that regulators say could raise crash risk. It is a software-fixable issue, but the headline adds to a list of scrutiny the company has faced recently. Watch for any pre-market softness in the stock before traders assess the actual scope of the recall.

Novo Nordisk is among the brighter movers overseas after its Q1 profit beat expectations. NVO has been in a tug-of-war all year between strong Wegovy demand and intensifying competitive pressure, so a positive earnings surprise carries real weight today. Philips is also worth a look in early trading after PHG beat on both revenue and margins with a strong North American order book backing it up.

HDFC Bank could see some quiet positive movement as well. Sources familiar with an ongoing governance review report that law firms examining the bank post its chairman's departure are not expected to flag major issues. That kind of uncertainty clearing tends to remove an overhang from HDB, even when the news is simply the absence of bad news.

Silicon Valley insider’s SHOCKING new AI prediction [ad]

🔍 Today's Watchlist

1. DIS earnings before the open: first report under CEO D'Amaro sets the narrative for 2026
2. NVO post-earnings price action after Q1 profit beat in a crowded GLP-1 market
3. BAYRY on asundexian stroke data: clinical wins can reprice biotech names fast
4. 10-Year yield at 4.42% ticking lower: watch how rate-sensitive sectors respond at the open
5. SpaceX IPO governance story: a proxy for how public markets will eventually price SPAC-adjacent names

🎯 The Morning Playbook

The setup for Wednesday is constructive. Futures up across the board, yields drifting lower, the dollar softening, and a genuine earnings catalyst in Disney to anchor the session. The temptation is to chase the green, but the more interesting play is watching how DIS reacts to its first report under new leadership. Beats on streaming and parks could fuel a meaningful move, while any guidance disappointment will test whether the broader market mood holds.

Healthcare is the sector to watch today with Novo Nordisk, Bayer, and Philips all in the conversation. The data points are mostly positive, and a softening dollar historically benefits large-cap multinationals with significant overseas revenue exposure, which describes all three.

Heading into the open, the tone feels genuinely firm rather than anxious. Lower yields, a weaker dollar, and strong pre-market futures are a combination that tends to reward patience over reactivity. Know what you own, know why you own it, and let the Disney number tell you something useful before making any big moves today.

Elon Did What?! [ad]